U.S. stocks were higher, with the Nasdaq Composite gaining around 1% on Monday.

Shares of Tango Therapeutics Inc (NASDAQ:TNGX) rose during Monday's session as the company announced positive initial data from its ongoing Phase 1/2 trial involving vopimetostat and daraxonrasib.

The results indicate a 90% progression-free survival rate at six months for patients with metastatic pancreatic ductal adenocarcinoma (PDAC).

Tango Therapeutics shares jumped 34.1% to $27.12 on Monday.

Here are some other big stocks recording gins in today's session.